Concepedia
Statistics
Publications
18
Citations
1.2K
H-Index
14
Active since
1995
Affiliations
Japanese Foundation For Cancer Research(Current)
Hokkaido University Hospital
Nanoco Technologies (United Kingdom)
University College London
Hokkaido University
Imad Naasani is an author at Japanese Foundation For Cancer Research specializing in pharmacology, pharmacy, and oncology.
Publications per year
1995–2022
Telomerase Inhibition, Telomere Shortening, and Senescence of Cancer Cells by Tea Catechins
Imad Naasani, Hiroyuki Seimiya, Takashi Tsuruo · Biochemical and Biophysical Research Communications · 1998 · 242 citations
Medicine, Cell Biology, Oncology +17
Blocking telomerase by dietary polyphenols is a major mechanism for limiting the growth of human cancer cells in vitro and in vivo.
Imad Naasani, Fujiko Oh-hashi, Tomoko Oh‐hara et al. · PubMed · 2003 · 204 citations
Medicine, Cancer Biology, Oncology +13
FJ5002: a potent telomerase inhibitor identified by exploiting the disease-oriented screening program with COMPARE analysis.
Imad Naasani, Hiroyuki Seimiya, Takao Yamori et al. · PubMed · 1999 · 157 citations
Pharmacy, Medicinal Chemistry, Pharmacology +16
Telomere shortening and growth inhibition of human cancer cells by novel synthetic telomerase inhibitors MST-312, MST-295, and MST-1991.
Hiroyuki Seimiya, Tomoko Oh‐hara, Tsuneji Suzuki et al. · PubMed · 2002 · 138 citations
Medicine, Oncology, Pharmacology +16
Hypoxia Up-Regulates Telomerase Activity via Mitogen-Activated Protein Kinase Signaling in Human Solid Tumor Cells
Hiroyuki Seimiya, Masanori Tanji, Tomoko Oh‐hara et al. · Biochemical and Biophysical Research Communications · 1999 · 96 citations
Life Sciences, Molecular Biology, Oncology +16
1–5 of 18